A Win For Anavex Life Sciences Corp.

Wed 04 Dec 19 at 05:30 PM
A Win For Anavex Life Sciences Corp.

Anavex Life Sciences Corp. (AVXL:NASDAQ) jumped higher at $3.03, representing a gain of 28.4%. On Tue 03 Dec 19, AVXL:NASDAQ touched a New 2-Week Intraday Low of $2.26. The stock got featured on our News Catalysts scanner on Wed 04 Dec 19 at 10:23 AM in the 'BIOTECH' category.

About Anavex Life Sciences Corp. (AVXL:NASDAQ)

Anavex Life Sciences Corp is a clinical stage bio-pharmaceutical company. The Company is engaged in the developments drug candidates to treat Alzheimer's disease, other central nervous system (CNS) diseases, and various types of cancer.

Share